These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Five-year real-world outcomes of anti-vascular endothelial growth factor monotherapy versus combination therapy for polypoidal choroidal vasculopathy in a Chinese population: a retrospective study. Yang J; Yuan M; Wang E; Xia S; Chen Y BMC Ophthalmol; 2019 Nov; 19(1):237. PubMed ID: 31752769 [TBL] [Abstract][Full Text] [Related]
28. Pigment epithelial tears after ranibizumab injection in polypoidal choroidal vasculopathy and typical age-related macular degeneration. Shin JY; Choi M; Chung B; Byeon SH Graefes Arch Clin Exp Ophthalmol; 2015 Dec; 253(12):2151-60. PubMed ID: 25744335 [TBL] [Abstract][Full Text] [Related]
29. Multicolour imaging for the detection of polypoidal choroidal vasculopathy and age-related macular degeneration. Tan CS; Ting DS; Lim LW Clin Exp Ophthalmol; 2019 Jul; 47(5):621-630. PubMed ID: 30578655 [TBL] [Abstract][Full Text] [Related]
30. Presenting characteristics and prevalence of polypoidal choroidal vasculopathy in Scandinavian patients with treatment-naïve exudative age-related macular degeneration. Lorentzen TD; Subhi Y; Sørensen TL Acta Ophthalmol; 2018 Aug; 96(5):475-480. PubMed ID: 29193780 [TBL] [Abstract][Full Text] [Related]
31. Associations of complement factor B and complement component 2 genotypes with subtypes of polypoidal choroidal vasculopathy. Tanaka K; Nakayama T; Mori R; Sato N; Kawamura A; Yuzawa M BMC Ophthalmol; 2014 Jun; 14():83. PubMed ID: 24965207 [TBL] [Abstract][Full Text] [Related]
32. EVEREST study report 4: Fluorescein angiography features predictive of polypoidal choroidal vasculopathy. Tan CS; Ngo WK; Lim LW; Tan NW; Lim TH Clin Exp Ophthalmol; 2019 Jul; 47(5):614-620. PubMed ID: 30652395 [TBL] [Abstract][Full Text] [Related]
34. Current Trends in Clinical Characteristics, Diagnosis, and Treatment of Polypoidal Choroidal Vasculopathy: A Perspective from Vietnam. Dat DT; Hien NDTN; Quan NN; Tung MQ; Tam HC; Hung BV J Clin Med; 2022 Aug; 11(16):. PubMed ID: 36012915 [TBL] [Abstract][Full Text] [Related]
37. Elevated C-reactive protein levels in patients with polypoidal choroidal vasculopathy and patients with neovascular age-related macular degeneration. Kikuchi M; Nakamura M; Ishikawa K; Suzuki T; Nishihara H; Yamakoshi T; Nishio K; Taki K; Niwa T; Hamajima N; Terasaki H Ophthalmology; 2007 Sep; 114(9):1722-7. PubMed ID: 17400294 [TBL] [Abstract][Full Text] [Related]
38. Replacement of polyps with type 1 macular neovascularization in polypoidal choroidal vasculopathy imaged with swept source OCT angiography. Shen M; Bo Q; Song M; Jiang X; Yehoshua Z; Gregori G; Sun X; Wang F; Rosenfeld PJ Am J Ophthalmol Case Rep; 2021 Jun; 22():101057. PubMed ID: 33796797 [TBL] [Abstract][Full Text] [Related]
39. Prognostic factors after aflibercept therapy for typical age-related macular degeneration and polypoidal choroidal vasculopathy. Ogasawara M; Koizumi H; Yamamoto A; Itagaki K; Saito M; Maruko I; Okada AA; Iida T; Sekiryu T Jpn J Ophthalmol; 2018 Sep; 62(5):584-591. PubMed ID: 29974277 [TBL] [Abstract][Full Text] [Related]
40. Polypoidal Choroidal Vasculopathy: Definition, Pathogenesis, Diagnosis, and Management. Cheung CMG; Lai TYY; Ruamviboonsuk P; Chen SJ; Chen Y; Freund KB; Gomi F; Koh AH; Lee WK; Wong TY Ophthalmology; 2018 May; 125(5):708-724. PubMed ID: 29331556 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]